Skip to content

Clinical trials

Terminated Phase 3 Heart Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 3 Status: Terminated Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20072
20083
20091
20113
20122
20151
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Forest Laboratories2
Abiomed Inc.1
Alexion Pharmaceuticals, Inc.1
Axio Research. LLC1
Biosense Webster, Inc.1
Bracco Diagnostics, Inc1
Cardium Therapeutics1
Denver Health and Hospital Authority1
Hamilton Health Sciences Corporation1
Idorsia Pharmaceuticals Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases17
Cardiovascular Diseases5
Myocardial Ischemia3
Arrhythmias, Cardiac2
Chest Pain2
Coronary Artery Disease2
Diabetes Mellitus2
Endocrine System Diseases2
Glucose Metabolism Disorders2
Heart Failure2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.